Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MERIT MEDICAL SYSTEMS INC Director's Dealing 2021

May 20, 2021

31049_dirs_2021-05-20_f2c74c35-014b-4f4b-997e-c763f8cf8cb4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MERIT MEDICAL SYSTEMS INC (MMSI)
CIK: 0000856982
Period of Report: 2021-05-17

Reporting Person: ANDERSON A SCOTT (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-17 Common Stock, No Par Value M 15000 $18.80 Acquired 33762 Direct
2021-05-17 Common Stock, No Par Value M 15000 $34.40 Acquired 48762 Direct
2021-05-17 Common Stock, No Par Value M 15000 $20.27 Acquired 63762 Direct
2021-05-17 Common Stock, No Par Value S 23779 $59.19 Disposed 39983 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-05-17 Non-qualified stock options (right to buy) $20.27 M 15000 Disposed 2022-05-22 Common Stock (15000) Direct
2021-05-17 Non-qualified stock options (right to buy) $18.8 M 15000 Disposed 2023-05-26 Common Stock (15000) Direct
2021-05-17 Non-qualified stock options (right to buy) $34.4 M 15000 Disposed 2024-05-24 Common Stock (15000) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-qualified stock options (right to buy) $50.5 2025-06-07 Common Stock (25000) 25000 Direct
Non-qualified stock options (right to buy) $52.17 2026-05-24 Common Stock (13750) 13750 Direct
Non-qualified stock options (right to buy) $52.17 2026-05-31 Common Stock (7500) 7500 Direct
Restricted Stock Unit $ 2021-06-22 Common Stock (4188) 4188 Direct

Footnotes

F1: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.51, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

F2: Becomes exercisable in equal annual installments of 20% commencing 05/22/2016.

F3: Becomes exercisable in equal annual installments of 20% commencing 05/26/2017.

F4: Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.

F5: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.

F6: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.

F7: Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.

F8: Each restricted stock unit represents a contingent right to receive one share of the issuer's Common Stock upon vesting.

F9: Each restricted stock unit vests on June 22, 2021 subject to continued service to the issuer through the vesting date.